Paired Somatic-Germline Testing of 15 Polyposis and Colorectal Cancer-Predisposing Genes Highlights the Role of APC Mosaicism in de Novo Familial Adenomatous Polyposis
Paula Rofes,Sara González,Matilde Navarro,José Marcos Moreno-Cabrera,Ares Solanes,Esther Darder,Estela Carrasco,Sílvia Iglesias,Mónica Salinas,Carolina Gómez,Àngela Velasco,Noemí Tuset,Mar Varela,Gemma Llort,Teresa Ramon Y Cajal,Èlia Grau,Núria Dueñas,Napoleón de la Ossa Merlano,Xavier Matías-Guiu,Bárbara Rivera,Judith Balmaña,Marta Pineda,Joan Brunet,Gabriel Capellá,Jesús Del Valle,Conxi Lázaro
DOI: https://doi.org/10.1016/j.jmoldx.2021.07.024
Abstract:Familial adenomatous polyposis (FAP) is an autosomal dominant syndrome responsible for 1% of colorectal cancers (CRCs). Up to 90% of classic FAPs are caused by inactivating mutations in APC, and mosaicism has been previously reported in 20% of de novo cases, usually linked to milder phenotypic manifestations. This study aimed to explore the prevalence of mosaicism in 11 unsolved cases of classic FAP and to evaluate the diagnostic yield of somatic testing. Paired samples of colorectal polyps, tumors, and/or mucosa were analyzed using a custom next-generation sequencing panel targeting 15 polyposis and CRC-predisposing genes. Whenever possible, the extension of mosaicism to blood or sperm was also examined. Of 11 patients with classic adenomatous polyposis, a mosaic pathogenic variant in APC was identified in 7 (64%). No other altered genes were identified. In two of seven patients (29%), mosaicism was found restricted to colonic tissues, whereas in five of seven patients (71%), it was extended to the blood. Germline affectation was confirmed in one patient. We report the first analysis at a somatic level of 15 genes associated with CRC susceptibility, which highlights the role of APC mosaicism in classic FAP etiology. The results further reinforce the importance of testing target tissues when blood test results are negative.